Bellevue Group AG Q3 2016 Filing
Filed November 10, 2016
Portfolio Value
$553.5B
Holdings
121
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (121 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MDTMedtronic PLC | 247,500 | $21.4B | 3.86% | |
| 2 | SYKStryker Corporation | 180,800 | $21.0B | 3.80% | |
| 3 | CELGCelgene Corporation | 194,250 | $20.3B | 3.67% | |
| 4 | ILMNIllumina, Inc. | 94,475 | $17.2B | 3.10% | |
| 5 | BIIBBiogen Inc. | 54,500 | $17.1B | 3.08% | |
| 6 | ABTAbbott Laboratories | 384,000 | $16.2B | 2.93% | |
| 7 | REGNRegeneron Pharmaceuticals, Inc. | 38,000 | $15.3B | 2.76% | |
| 8 | AMGNAmgen Inc. | 83,500 | $13.9B | 2.52% | |
| 9 | UNHUnitedHealth Group Incorporated | 99,200 | $13.9B | 2.51% | |
| 10 | BSXBoston Scientific Corporation | 575,000 | $13.7B | 2.47% | |
| 11 | GILDGilead Sciences, Inc. | 156,500 | $12.4B | 2.24% | |
| 12 | LGNDLigand Pharmaceuticals Incorporated | 106,880 | $10.9B | 1.97% | |
| 13 | ZBHZimmer Biomet Holdings, Inc. | 80,000 | $10.4B | 1.88% | |
| 14 | EWEdwards Lifesciences Corporation | 85,000 | $10.2B | 1.85% | |
| 15 | JAZZJazz Pharmaceuticals Public Limited Company | 83,800 | $10.2B | 1.84% | |
| 16 | BDXBecton, Dickinson and Company | 55,000 | $9.9B | 1.79% | |
| 17 | CNCCentene Corporation | 141,430 | $9.5B | 1.71% | |
| 18 | HOLXHologic, Inc. | 242,100 | $9.4B | 1.70% | |
| 19 | BAXBaxter International Inc. | 190,000 | $9.0B | 1.63% | |
| 20 | —Mylan N V | 235,700 | $9.0B | 1.62% | |
| 21 | CAHCardinal Health, Inc. | 114,280 | $8.9B | 1.60% | |
| 22 | ISRGIntuitive Surgical, Inc. | 12,000 | $8.7B | 1.57% | |
| 23 | TEVATeva Pharmaceuticals Industries Ltd | 187,190 | $8.6B | 1.56% | |
| 24 | INCYIncyte Corporation | 91,000 | $8.6B | 1.55% | |
| 25 | CICigna Corporation | 59,722 | $7.8B | 1.41% | |
| 26 | VRTXVertex Pharmaceuticals Incorporated | 85,000 | $7.4B | 1.34% | |
| 27 | —Shire PLC | 38,090 | $7.4B | 1.33% | |
| 28 | ABMDEURAbiomed Inc | 55,450 | $7.1B | 1.29% | |
| 29 | —Akorn Inc | 252,000 | $6.9B | 1.24% | |
| 30 | —ARIAD Pharmaceuticals, Inc. | 495,000 | $6.8B | 1.22% | |
| 31 | —Allergan PLC | 29,400 | $6.8B | 1.22% | |
| 32 | CERNCHFCerner Corporation | 98,500 | $6.1B | 1.10% | |
| 33 | ALXNAlexion Pharmaceuticals, Inc. | 49,400 | $6.1B | 1.09% | |
| 34 | BMRNBioMarin Pharmaceutical Inc. | 65,000 | $6.0B | 1.09% | |
| 35 | JNJJohnson & Johnson | 50,000 | $5.9B | 1.07% | |
| 36 | —Mallinckrodt Pub Ltd Co. | 80,800 | $5.6B | 1.02% | |
| 37 | BCRUSDC.R. Bard, Inc. | 25,000 | $5.6B | 1.01% | |
| 38 | CHRSCoherus BioSciences, Inc | 202,000 | $5.4B | 0.98% | |
| 39 | —Amsurg Corp | 71,400 | $4.8B | 0.86% | |
| 40 | COOCooper Companies Inc. | 23,500 | $4.2B | 0.76% | |
| 41 | 3M4Masimo Corporation | 70,000 | $4.2B | 0.75% | |
| 42 | MCKMcKesson Corporation | 24,000 | $4.0B | 0.72% | |
| 43 | NUVAGBPNuvasive, Inc. | 60,000 | $4.0B | 0.72% | |
| 44 | ISIIonis Pharmaceuticals Inc. | 108,000 | $4.0B | 0.71% | |
| 45 | PRGOPerrigo Company plc | 42,700 | $3.9B | 0.71% | |
| 46 | IBBiSHARES Trust | 13,500 | $3.9B | 0.71% | |
| 47 | HALOHalozyme Therapeutics, Inc. | 318,000 | $3.8B | 0.69% | |
| 48 | —Endo International PLC | 190,000 | $3.8B | 0.69% | |
| 49 | —Auris Medical Holding AG | 2,169,625 | $3.8B | 0.68% | |
| 50 | —Express Scripts Holding Company | 49,500 | $3.5B | 0.63% | |
| 51 | —Radius Health Inc. | 61,000 | $3.3B | 0.60% | |
| 52 | —Intersect Ent, Inc. | 205,325 | $3.3B | 0.59% | |
| 53 | NKTREURNektar Therapeutics | 186,000 | $3.2B | 0.58% | |
| 54 | RAREUltragenyx Pharmaceuticals Inc. | 43,000 | $3.0B | 0.55% | |
| 55 | NBIXNeurocrine Biosciences, Inc. | 58,000 | $2.9B | 0.53% | |
| 56 | MRKMerck & Co., Inc. | 47,000 | $2.9B | 0.53% | |
| 57 | LLYLilly Eli & Co. | 35,000 | $2.8B | 0.51% | |
| 58 | —Novadaq Technologies Inc. | 230,000 | $2.7B | 0.48% | |
| 59 | ELVAnthem, Inc. | 20,600 | $2.6B | 0.47% | |
| 60 | TMOThermo Fisher Scientific Inc. | 16,000 | $2.5B | 0.46% | |
| 61 | QGENQiagen NV | 91,500 | $2.5B | 0.45% | |
| 62 | MGNXMacrogenics, Inc. | 83,000 | $2.5B | 0.45% | |
| 63 | PRTAProthena Corporation plc | 41,000 | $2.5B | 0.44% | |
| 64 | ALKSAlkermes Public Limited Company | 51,500 | $2.4B | 0.44% | |
| 65 | AGIOAgios Pharmaceuticals, Inc. | 45,000 | $2.4B | 0.43% | |
| 66 | HCAHCA Holdings, Inc. | 31,200 | $2.4B | 0.43% | |
| 67 | —Zeltiq Aesthetics Inc. | 60,000 | $2.4B | 0.43% | |
| 68 | SGENEURSeattle Genetics, Inc. | 43,000 | $2.3B | 0.42% | |
| 69 | ANGOAngioDynamics, Inc. | 130,000 | $2.3B | 0.41% | |
| 70 | —Impax Laboratories, Inc. | 95,000 | $2.3B | 0.41% | |
| 71 | ICPTUSDIntercept Pharmaceuticals, Inc. | 13,500 | $2.2B | 0.40% | |
| 72 | BIBProShares Trust | 45,500 | $2.2B | 0.40% | |
| 73 | —Horizon Pharma plc | 117,000 | $2.1B | 0.38% | |
| 74 | EGRXEagle Pharmaceuticals Inc. | 29,000 | $2.0B | 0.37% | |
| 75 | GMEDGlobus Medical, Inc. | 87,700 | $2.0B | 0.36% | |
| 76 | —Bluebird Bio, Inc. | 29,000 | $2.0B | 0.36% | |
| 77 | —Achillion Pharmaceuticals, Inc. | 240,000 | $1.9B | 0.35% | |
| 78 | HUMHumana, Inc. | 10,800 | $1.9B | 0.35% | |
| 79 | —Aetna Inc. | 16,400 | $1.9B | 0.34% | |
| 80 | —Wright Med Group N V | 70,309 | $1.7B | 0.31% | |
| 81 | PFEPfizer Inc. | 50,000 | $1.7B | 0.31% | |
| 82 | ALNYAlnylam Pharmaceuticals Inc. | 24,000 | $1.6B | 0.29% | |
| 83 | CLVSEURClovis Oncology Inc. | 43,000 | $1.6B | 0.28% | |
| 84 | HCSGHealthcare Services Group Inc. | 38,100 | $1.5B | 0.27% | |
| 85 | INOInovio Pharmaceuticals, Inc. | 155,000 | $1.4B | 0.26% | |
| 86 | ACADAcadia Pharmaceuticals, Inc. | 45,000 | $1.4B | 0.26% | |
| 87 | INSYEURInsys Therapeutics Inc. | 115,000 | $1.4B | 0.24% | |
| 88 | —Alere Inc | 30,000 | $1.3B | 0.23% | |
| 89 | BMYBristol-Myers Squibb Company | 23,000 | $1.2B | 0.22% | |
| 90 | LABUUSDDirexion SHS ETF TR | 25,175 | $1.2B | 0.22% | |
| 91 | —Juno Therapeutics, Inc. | 37,000 | $1.1B | 0.20% | |
| 92 | —Laboratory Corporation of America Holdings | 8,000 | $1.1B | 0.20% | |
| 93 | TFXTeleflex Incorporated | 6,500 | $1.1B | 0.20% | |
| 94 | —Alder Biopharmaceuticals Inc. | 33,000 | $1.1B | 0.20% | |
| 95 | MOHMolina Healthcare Inc. | 16,500 | $962.0M | 0.17% | |
| 96 | ABBVAbbvie Inc. | 15,000 | $946.0M | 0.17% | |
| 97 | —Envision Healthcare Hldgs Inc. | 39,000 | $869.0M | 0.16% | |
| 98 | CVSCVS Health Corporation | 9,700 | $863.0M | 0.16% | |
| 99 | —Quotient Limited | 110,000 | $860.0M | 0.16% | |
| 100 | —Portola Pharmaceuticals Inc. | 36,000 | $818.0M | 0.15% |
Page 1 of 2Next